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The human gut microbiome has emerged as a key player in the bidirectional communica-
tion of the gut–brain axis, affecting various aspects of homeostasis and pathophysiology.
Until recently, the majority of studies that seek to explore the mechanisms underlying the
microbiome–gut–brain axis cross-talk, relied almost exclusively on animal models, and
particularly gnotobiotic mice. Despite the great progress made with these models,
various limitations, including ethical considerations and interspecies differences that limit
the translatability of data to human systems, pushed researchers to seek for alternatives.
Over the past decades, the field of in vitro modelling of tissues has experienced tremen-
dous growth, thanks to advances in 3D cell biology, materials, science and bioengineer-
ing, pushing further the borders of our ability to more faithfully emulate the in vivo
situation. The discovery of stem cells has offered a new source of cells, while their use in
generating gastrointestinal and brain organoids, among other tissues, has enabled the
development of novel 3D tissues that better mimic the native tissue structure and func-
tion, compared with traditional assays. In parallel, organs-on-chips technology and bioen-
gineered tissues have emerged as highly promising alternatives to animal models for a
wide range of applications. Here, we discuss how recent advances and trends in this
area can be applied in host–microbe and host–pathogen interaction studies. In addition,
we highlight paradigm shifts in engineering more robust human microbiome-gut-brain
axis models and their potential to expand our understanding of this complex system and
hence explore novel, microbiome-based therapeutic approaches.
Introduction
Over the past decades, the integral role that gut microbiota play in human health and disease has been
extensively studied and it is now apparent that the intestinal flora is a critical determinant and regulator
of host physiology [1]. The gastrointestinal (GI) tract harbours a complex and dynamic population of
over 100 trillion microbes, which have co-evolved with the host to form a mutually beneficial — symbi-
otic — relationship. These commensals are now known to participate in various fundamental processes
of the human body, including digestion, energy metabolism, intestinal barrier function and homeostasis,
immunity and production of vitamins and anti-inflammatory moieties [2]. The gut microbiota profile of
each individual is unique and dynamic; established in early life and shaped with age by various factors
(e.g., mode of birth, diet, exercise, genetics, lifestyle, the potential use of antibiotics and other medica-
tion) [2,3]. While microbiome maturation during development and ageing is naturally occurring and
results in desirable compositional and functional changes with protective effects against inflammation
and other disorders [1], a scrutiny of studies has revealed recently the connection between several patho-
physiological conditions with an impaired gut microbiome, the effects of which extend beyond the gut
and, in particular, to the brain [3–7]. Although the concept of bidirectional communication between the
gut and the brain, termed the gut-brain axis, is far from new, it is now becoming apparent that microbes
in the gut also participate in this interplay, considerably affecting neural function and pathophysiology
(e.g., response to stress, susceptibility to autism, neurodegenerative diseases) [2,8]. Recent developments
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in the field suggest that communication in the microbiome-gut-brain axis occurs via several routes, (Figure 1)
including the vagus nerve and the enteric nervous system (ENS), the immune system and enteroendocrine signal-
ling pathways, as well as via release of microbial metabolites in systemic circulation [9]. However, the exact
molecular and cellular mechanisms by which gut microbes transmit signals across the intestine and access the
brain remain poorly understood not only due to the biological complexity of host–microbe interactions, but also
due to the lack of appropriate tools [10,11].
Animal models and, specifically germ-free and gnotobiotic mice, have been invaluable for expanding our
understanding on how microbiota and its alterations shape GI and brain (patho-)physiology and for establish-
ing causal links between specific microbial cohorts and disease phenotypes [12–15]. But these models exhibit
several limitations that render translation of data from animal to human systems quite challenging. Besides the
ethical considerations, the high expenses, the time-consuming and labour-intensive nature of animal studies,
rodents often fail to recapitulate human conditions due to inter-species differences related to gut topology,
immune system and brain function (e.g., cognition), as well as differences in the wild-type microbiome profile
and molecular mechanisms involved in the onset and progression of diseases [12,16]. While these models are
still relevant and useful for a breadth of applications, in recent years, in vitro models of human systems have
emerged as powerful tools that can be used in parallel with or, in some cases, alternative to animal studies.
Currently, a wide range of engineered in vitro models are available, aiming to systematically investigate the
complex cross-talk of microbes and human tissues in a more simplified context, within well-controlled and
reproducible conditions for the evaluation of individual cell/tissue responses [11,12,16,17]. Early attempts
involved conventional culture setups where intestinal cells were exposed to distinct microbiota, or neuronal
cells were exposed to circulating gut-derived microbial metabolites, and the effects on host cells were evaluated
via various assays, including permeability assays, multi-omic analyses, TEER, imaging [18–23]. Other
approaches involved multi-compartment fermenting bioreactors, mimicking intestinal physiological character-
istics along with the growth of commensal microbes, facilitating indirect, long-term studies [24–26]. Although
such models allowed insight into many aspects of host-microbiome cross-talk, their inherent drawbacks (e.g.,
use of cell lines with cancerous origin, lack of bacterial and host cellular diversity, oversimplification, lack of
host feedback mechanisms, absence of representative cross-talk) [12,17] restrict the extent to which the in vivo
situation can be emulated to capture the complexity of the microbiome-gut-brain axis in its entirety. Therefore,
novel bioengineering tools have been called for, for the development of more physiologically relevant human in
Figure 1. Communication pathways of the microbiota-gut-brain axis.
The proposed mechanisms through which microbiota can signal the brain: (A) production of microbial metabolites that can
reach the brain via the systemic circulation; (B) enteroendocrine system and gut hormone and neurotransmitter signalling
pathways; (C) vagus nerve and ENS signalling pathways; (D) recruitment of the immune system, cytokine release and
neuroimmune interactions. Created with BioRender.com.
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vitro models. This minireview highlights the latest advances and paradigms in engineering such models, with
the potential to generate more accurate and translatable data and, hence, (i) dissect the intricate interplay of
microbiota and the gut-brain axis, (ii) improve our understanding of the microbiota alteration effects on host
pathophysiology and (iii) lay the foundation for the development of new, personalised, microbiome-based drug
and treatment approaches.
Advanced tools for modelling the human
microbiome-gut-brain axis in vitro
Over the past decades, a series of advances in three-dimensional (3D) cell biology and tissue engineering have
enabled researchers to build more robust tools to better recapitulate native human tissue in vitro [27–29]. The dis-
covery of induced pluripotent stem cells (iPSCs) and the subsequent establishment of long-term organotypic
intestinal and brain cultures derived from human subjects enabled the development of novel cell systems, opening
new avenues for expanding our scientific knowledge on host-microbiome interactions, among other applications
[10,29]. In parallel, bioengineering approaches, that make use of biomimetic substrates (i.e., scaffolds and hydro-
gels) in combination with the appropriate cell sources and biochemical and biophysical cues, have gained a lot of
attention recently for modelling tissues of higher biomimicry and physiological relevance [28,30]. In addition,
new culturing technologies, using advanced media formulations and anaerobic conditions in specially designed
platforms, have made possible mechanistic studies of difficult-to-culture or previously uncultivable gut microbes
[31–33]. Such methods, along with powerful high-throughput next-generation genomic and metagenomic sequen-
cing, permitted compositional and functional analyses to determine the dynamics of the complex gut microbiota
community and their role in human health, completely transforming research approaches in the field [34,35].
Organoids
Organoids have proven to be valuable in vitro cell systems for various biomedical applications, ranging from
tissue homeostasis, disease modelling and drug testing to regenerative medicine and host–microbe interactions
[36,37]. Currently, various protocols exist for establishing both GI and brain organoids, derived from adult
tissue biopsies and iPSCs. These 3D self-organised tissue constructs exhibit in vivo-like architecture, regional
specification and diverse cellular subtypes, more faithfully mimicking major features of the human native
tissues compared with cell lines and animal models [10,38–41]. The presence of a variety of functional enter-
oendocrine cells in GI organoids, and in particular enterochromaffin cells which have been shown to trigger
the ENS and to transduce chemosensory signals to the brain, allows modelling of aspects of the bidirectional
communication of the gut-brain axis [42], while various GI organoid systems have offered valuable insight into
both host-commensal and host–pathogen interactions. (See Table 1) As the lumen of GI organoids is enclosed
in the centre of the construct and the basal membrane is displayed outwards, a popular technique to deliver
microbiota or their metabolites to the apical surface of the epithelium is microinjection [43,44]. With this
method, the internal niche required by microbes is preserved and is more suitable for studying long-term inter-
actions with commensals or pathogens that normally infect the host from the lumen. However, it requires
special equipment and it is quite challenging to perform reproducible and quantitative experiments, while
damage of organoids during the process is often [44]. In an attempt to overcome these challenges, Co and col-
laborators [45] developed a technique to reverse the polarity of enteroids, to expose their apical surface to the
media without compromising the structure and function of the intestinal constructs, and successfully used this
to identify the infection patterns of invasive enteropathogens (Figure 2A). Alternatively, GI organoids are rou-
tinely grown before enzymatically dissociated and reseeded onto Transwell culture inserts or Matrigel/ECM
coated dishes, where they form monolayers that comply with the epithelial barrier dynamics and allow for
exposure of the apical/luminal surface to microbes or their metabolites, added in the culture medium [10,44].
Although these monolayers contain the same cellular diversity as the organoids they are derived from, they fail
to capture the 3D microenvironment of the native tissue and may not be suitable for long-term experiments
[10,44]. Finally, disruption of organoids into suspensions, and then mixing with microbes and subsequent cul-
tivation in 3D matrices to reform organoids, has also been used in host–microbe interaction studies. Despite
the straightforward nature of this method, such approaches do not accurately capture the infection mechanism
for all types of microorganisms, as some may interact with the basal side of the cells within the constructs,
inducing non-specific responses [44]. There is currently insufficient evidence of one technique being superior
to the other in capturing the in vivo situation, rather, the choice of method is based on the nature of the
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Table 1. Examples of human GI organoid cultures for studying host–microbe and host–pathogen interactions. Part 1 of 2
Microbe(s)/
metabolites Organoid Method Main findings References
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question being asked [10]. Despite the great potential of GI organoids as in vitro human models, the inherent
limitations of reproducing age-associated structural and functional aspects of the native tissue, the
batch-to-batch heterogeneity in size and, most importantly, the lack of essential components of their living
counterparts, including the vasculature, the ENS and the immune system, hinders their use in studies looking
Table 1. Examples of human GI organoid cultures for studying host–microbe and host–pathogen interactions. Part 2 of 2
Microbe(s)/
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at microbiome-gut-brain signalling pathways. To overcome this challenge, efforts are being made to develop
co-cultures of GI organoids with immune cells and/or enteric neurons [46,47]. Brain organoids have also been
used to study neuro-immune, neuro-endocrine [48] and host–microbe interactions, including Zika virus,
[49–51] Toxoplasma gondii, [52] congenital human cytomegalovirus (HCMV) [53] and Japanese encephalitis
virus ( JEV) [54]. Advances in (patient) iPSC-derived GI, ENS and brain organoids with vagal nerve neurons,
as well as in methods to co-culture these components, could provide in the future a means to model the gut-
brain connection and study the role of microbiota in various aspects of human health and disease [48].
Organs-on-chips
In parallel with advances in 3D cell biology and organotypic cultures, organs-on-chips (OOCs), alternatively
called microphysiological systems (MPS), have also been used for modelling aspects of the microbiota-gut-brain
axis. Combining principles of microengineering and fluidics with trends in growing cells in 3D, such models
allow for cultivating human tissues in a more biomimetic microenvironment, where cells are exposed to
tissue-relevant biochemical and biophysical cues (e.g., fluid shear stress, peristalsis) [70,71]. In addition, OOCs
offer unparalleled, independent spatiotemporal tuning and control over multiple key factors of the cell system
(e.g., O2, pH), in situ, automated monitoring and sample analysis along with downstream analysis, as well as the
potential to study cell-cell and cell-niche interactions [71]. The benefits of these animal-free and more
Figure 2. Examples of in vitro human intestinal models for studying host-microbe and host-microbiome interactions.
(A) S. Typhimurium-mCherry infection of human enteroids. Selective invasion of the exposed apical surface (green arrows) of a mixed polarity
enteroid (left). 3D confocal reconstruction of S. Typhimurium-mCherry within an epithelial cell in the process of extruding from the apical enteroid
surface (right) (nuclei in blue, actin in white). Adapted from [45] under the Creative Commons license; (B) Conceptual diagram of the HuMiX model
for the representative co-culture of human epithelial cells with gastrointestinal microbiota. Reproduced from [55], under the Creative Commons
license; (C) Schematic of C. difficile infection in the 3D scaffold tissue model (left) and scanning electron microscopy of uninfected (left column) and
infected with UK1 C. difficile 3D scaffolds (right column) at 4, 24 and 48 h (right). Adapted from [23].
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physiologically relevant models have been exploited recently for the development of guts-on-chips, aiming to
mimic specific tissue structural and functional features (e.g., villus-crypt formation, mucus layer). Such approaches
for engineering the gut microenvironment are superior to conventional in vitro models, as they enable continuous
supply of nutrients and waste removal, incorporation of components of the vascular and immune systems and
intestinal flora, [70,72] (See Table 2) and, in some cases, application of mechanical deformations to mimic gut
peristaltic movements [73]. Some approaches are also focused on incorporating sensing units that allow for real-
time monitoring of key parameters and factors, such as O2 [74] and barrier integrity, [75,76] which are important
readouts for studies looking at the effects of microbes on the epithelium. Among the latest achievements in this
field is the development of gut OOCs using hiPSCs and organoid-derived cells, both from healthy individuals or
patients, in order to generate models that better capture the complexity of the intestinal epithelium in each condi-
tion [77]. Insights into host-microbiome interactions were achieved recently using this technology. For example,
Shah et al. built a modular gut OOC that recapitulates the human GI-microbiome interface (Figure 2B) and used
it to study the metabolic and immunological responses of the intestinal epithelium upon co-culture with com-
mensal anaerobes [55]. A more recent approach modelled a human anaerobic intestine-on-chip, establishing a
hypoxia gradient across the endothelium-epithelium interface, and was successfully used for an extended, stable
co-culture of human intestinal tissue with a highly complex human-derived gut microbiota cohort, providing a
valuable tool for more in-depth studies of host-microbiome cross-talk [74].
Similarly, OOC technology has been used for generating more robust models of the BBB and/or the brain,
[80–86] which have shown great potential for testing whether drug candidates can actually cross the BBB and
Table 2. Examples of gut-microbiome OOC devices
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reach their target in the brain [87]. However, such models are of great importance for modelling the BBB and
brain per se, as current gold standards often fail to capture the complex structural and functional aspects of the
human brain [81]. Although the effects of gut commensal metabolites on the brain have been demonstrated in
in vitro models of the human BBB, [19] the potential of single BBB and/or brain OOCs has not yet been
employed in microbiome research. Indeed, the benefits of each of the OOCs required to mimic the
microbiota-gut-brain axis in vitro have been demonstrated individually [88]. However, there is much interest in
functionally coupling individual OOCs via their endothelium/vascular channel in an in vivo-like sequence
towards multi-organ OOC systems that reconstitute the role of vasculature perfusion and the cross-talk
between the tissues of interest [89–91]. Recently, this concept was shown to be particularly apt for studying the
effects of microbiota in the brain in a study coupling individual OOCs mimicking the gut-liver-kidney-brain
axis, where the toxicity of the microbiome metabolites trimethylamine (TMA) and trimethylamine-N-oxide
(TMAO) were tested and exhibited that TMAO can pass through the BBB to reach the NVU [91].
3D Bioengineering approaches
Even though the fast-growing OOC technology has emerged as a highly promising tool for various biomedical
applications, the field is still relatively young, with various challenges to be addressed [88]. Indeed, OOC
approaches have been shown to more faithfully mimic the in vivo microenvironment compared with conven-
tional culture systems. However, in most cases they form a quasi-3D cell system, not entirely capturing struc-
tural and functional features of the native tissue. To overcome this limitation, TE approaches have been called
for generating truly 3D tissues, where gels and scaffolds are used as templates, combined with the appropriate
cell source (i.e., stem cells, organoids) and tissue-relevant environmental cues [92,93]. Such bioengineering
approaches facilitated the development of more robust gut-like [94–100] and brain-like [101–105] tissue
equivalents, significantly improving our ability to model various aspects of their (patho-) physiology. In one of
the seminal studies towards this end, the researchers engineered 3D porous scaffolds using silk protein, featur-
ing a hollow lumen with a polarised monolayer of human intestinal epithelial cells, supported by myofibroblasts
cultivated in the scaffold bulk. These intestinal tissues exhibited characteristic functions of the human intestine,
including mucus layer formation and low oxygen tension in the lumen, while able to interact with gut-
colonising bacteria[106] as well as supporting studies of C. difficile germination, colonisation, toxin production
and epithelial damage (Figure 2C) [23]. More recently, the group developed a perfused bioreactor system to
host these intestinal tissues, offering better control over oxygen levels and physicochemical parameters, [107]
while also reported the integration of a functional stem cell-derived ENS towards innervated intestinal con-
structs, particularly apt for studies looking at ENS-mediated communication networks [108].
However, in most cases 3D bioengineered tissues lack in-line monitoring units that would allow for real-time
assessment and interrogation of the cell state and activity, mainly relying on end-point assays and downstream
analysis [16]. To overcome this limitation, we recently developed 3D tubular scaffolds based on conducting
polymers that act both as hosts of 3D cell systems and as active elements for continuous monitoring of cell
activity and integrity. By tailoring the electrical, mechanical and biochemical properties of the materials we
were able to generate a bioelectronic platform for successfully growing 3D mammalian tissue over a period of 4
days during which electrical readouts helped us to monitor cells and distinguish between adhesion and barrier
tissue formation [109]. This novel in vitro tool forms the basic technological brick for our ERC funded project
‘IMBIBE’ (grant agreement No. 723951), which aims to generate a complete platform of the human
microbiota-gut-brain axis with integrated monitoring and sensing capabilities (Figure 3A–C). Bringing together
principles of materials science, tissue engineering, 3D cell biology and bioelectronics, we are currently building
advanced models of the GI and the BBB/NVU, towards robust and more physiologically relevant human in
vitro models. The innovation in IMBIBE comes from focusing on an in vivo-like 3D environment, using novel
sources of human cells (i.e. cell lines, stem cell-derived or organoid-derived cells), while also benefitting from
cutting edge organic electronic technology for multi-parameter and real-time monitoring, compatible with and
adapted to the cell systems. Our models are designed to have sufficient complexity to produce predictive data,
useful in understanding the interactions between the biological components, while being reductionist enough
to facilitate alterations of system parameters to answer specific biological questions. In parallel, the integrated
electronic assays allow for continuous collection of data to assess the model with a variety of different readouts,
targeted for different biological questions. We recently demonstrated the unparalleled capabilities our systems
bring in engineering tissues in vitro by generating the 3D bioelectronic human intestinal module of the
IMBIBE platform, the L-Tubistor [110]. The module is based on the aforementioned tubular electroactive
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scaffolds, in the centre of which a hollow channel was introduced to mimic the native tissue luminal architec-
ture. The L-Tubistor scaffolds were shown to support the growth and maintenance of an in vivo-like stratified
and polarised intestinal tissue for the extended period of ∼1 month. Continuous monitoring of the changes in
the electrical properties of the scaffold, induced by interactions with cells and extracellular matrix, provided
unprecedented real-time information on tissue formation and integrity with a highly sensitive multi-modal
operation (i.e., as an electrode and as a transistor), in a non-invasive manner (Figure 3D). The methodology
for tissue growth within the L-Tubistor can be adapted to build the other modules of the IMBIBE platform,
while its compatibility with fluidics will enable the functional coupling of these modules towards the desired
Figure 3. Design and tools of the IMBIBE platform.
(A) Modules of the microbiota-gut-brain axis segments are built to operate independently but can also be interconnected to
mimic the in vivo situation, by means of fluidic coupling and interconnection of each tissue equivalent via their bulk
compartments; (B) Illustration of the biological components of the complete IMBIBE platform; Created with BioRender.com (C)
Schematic of the structure and setup of the ‘Tubistor’, the novel 3D bioelectronic device for building each module of the IMBIBE
platform. Reproduced from [109] under the Creative Commons License. (D) The gut module of the IMBIBE platform, hosted in the
new generation of the device in (C) — the ‘L-Tubistor’ — modified to better capture the native tissue architecture. A schematic
illustration of the intestinal model showing the organisation of different cell components in the hollow tubular electroactive
scaffolds of the L-Tubistor (top). Snapshot of z-stacked confocal images illustrating the brush border of the polarised intestinal
epithelial layer on the scaffold lumen lining (middle; scale bar 20 mm). Representative graph of electrical monitoring of the
intestinal model showing the response of the electroactive scaffolds to tissue formation from day 4 of fibroblast culture to day 22
of intestinal cell culture (overall day 26; bottom). Adapted from [110] under the Creative Commons License.
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multi-organ-on-a-chip. We envision that our IMBIBE platform will aid the research efforts to (i) elucidate the
role of microbiota in the gut-brain axis communication, (ii) to study how diet and impaired microbiota profiles
affect various (patho-) physiologies, and (iii) to test personalised medicine approaches for disease modelling
and drug testing studies.
Conclusions
The intricate interplay between the gut and the brain has long been appreciated. However, over the
past decades, great attention has been given to the role of microbiota in this bidirectional communication
and its effects on various aspects of health and disease. Although much of our understanding about the
microbiota-gut-brain axis comes from animal models, their inherent shortcomings and inability to reproduce
the human situation have turned the attention of the research community to in vitro models. The advent of
hiPSCs and organoids provided researchers with robust organotypic cell systems for emulating parts of the gut-
brain axis and interfacing them with microbiota. In parallel, OOCs and 3D bioengineered tissues have emerged
as powerful tools, advancing our ability to more faithfully emulate human tissues in vitro within a controllable
and reproducible environment. Despite their reductionist nature, various gut-microbiome models have success-
fully been implemented in studies looking at host–microbe interactions, offering crucial insight into the effects
of microbes on the intestinal epithelium homeostasis and infection mechanisms. However, there is currently no
in vitro model of the complete microbiota-gut-brain axis and many challenges remain to be addressed before
such a single platform is engineered (e.g., inclusion of all representative cell types in stable and viable
co-cultures for long-term experiments, in situ sample analysis and monitoring units). Functional, modular
coupling of the microbiota-gut-brain axis experimental constituents holds great potential for effectively model-
ling the axis in its entirety. It is apparent that this is a multidisciplinary field, requiring close collaboration of
different fields to resolve both technological and biological obstacles. We expect that further advances in bio-
engineering, stem cell biology and organoid systems will facilitate the generation of robust and reliable in vitro
models to support comprehensive studies of the mechanisms underlying the complex cross-talk in the
microbiome-gut-brain axis, as well as to explore novel microbiome-based therapeutic approaches.
Perspectives
• The gut microbiome has emerged as a key determinant and regulator of gut-brain homeosta-
sis. Although accumulating evidence links the intestinal flora with various diseases and disor-
ders, the mechanisms underlying the intricate host-microbiome cross-talk have not yet been
fully understood.
• Interspecies differences, among other shortcomings of animal models, have pushed research-
ers to look for more relevant human models. Several frameworks have been put forward to
engineer in vitro models of the human microbiota-gut-brain axis, including organoid cultures,
OOCs and 3D bioengineered tissues.
• Currently, no single platform exists recapitulating the complete axis. Efforts are focused on
resolving both the biological and technological limitations of the current state-of-the-art, by
generating more robust cell culture systems and by optimising the design, material properties
and fabrication methods of the platforms that will support the maintenance and characterisa-
tion of the models, respectively.
Box 1. Glossary
Microbiota and microbiome: The terms are often used interchangeably to describe the commu-
nity of commensal, symbiotic and pathogenic microorganisms present in a defined environment,
including the body or parts of the body, such as the gut. See [111] for a detailed description of
microbiome definitions. The term microbiome is mostly used to refer to the collective genomes of
the microorganisms in a specific environment, while the term microbiota refers to the assemblage
of the microorganisms per se [112].
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Gnotobiotic animals: Refers to animals in which every microorganism present is defined.
Germ-free mice, commonly used in microbiome research, are one class of gnotobiotic animals,
as well as mice associated with defined bacterial communities [113].
Microbiota-Gut-Brain axis: The bidirectional communication between the microbiota, the gut and
the brain through encompassing distinct pathways of the autonomic nervous system (ANS), the
enteric nervous system (ENS), the hypothalamic-pituitary-adrenal axis (HPA), the neuroimmune
system and metabolites translocating from the intestinal mucosa into the bloodstream. See [1] for
a comprehensive review.
Organoids: Generally the term is used to refer to self-organising in vitro structures resembling an
organ. More specifically though ‘a genuine organoid should satisfy several criteria: (1) a 3D struc-
ture containing cells that establish or retain the identity of the organ being modelled; (2) the pres-
ence of multiple cell types, as in the organ itself; (3) the tissue exhibits some aspect of the
specialised function of the organ; and (4) self-organisation according to the same intrinsic orga-
nising principles as in the organ itself’ [114]. Enteroids (small intestine) and colonoids (large intes-
tine/colon) are precursors of organoids, formed at initial stages of the organoid cultures,
containing only epithelial cell types. See [115].
Organotypic cultures: Approaches of reconstituting organ function ex vivo, including 3D cell
culture systems, explants-tissue slices and organoids [116].
Organs-on-chips (OOCs): Emerging interdisciplinary technology that combines principles of
microfluidics and microengineering, cell biology, tissue engineering, aiming to develop miniature
tissues and organs in vitro that capture key architectural and functional aspects of a specific
human tissue. These models represent promising alternatives to animal studies for investigating
physiological and pathological events of the tissue as well as for testing drug and treatment can-
didates by generating more accurate and translatable results. See [71,72] for latest advances and
trends in the field.
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